← Back
Bone Biologics
BBLG · listed on Nasdaq · worth $1.32 million
$0.3883
−0.94% on Oct 29
No insider trades reported for Bone Biologics yet.
No insider trades or company news in this range.
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
3.4M shares
100% of all shares
Shares borrowed and sold by investors who expect the price to drop.
All reports
Every insider trade and SEC report we hold for Bone Biologics.
Newest first
No insider trades reported for BBLG yet.
Analysts, earnings and news
Analysts' price target
$12.20 average
1 analyst
Analysts' opinions, which tend to run optimistic. Not our forecast or advice.
Profit vs what was expected
2 of 4 quarters above
Q2 '26−$0.43 a share−$0.04
Q1 '26−$0.43 a share+$0.11
Q4 '25−$0.63 a share−$0.29
Q3 '25−$0.37 a share+$0.86